the planned acquisition of the US seed company is likely to be even more expensive for Bayer (Photo: AFP)
Hamburg / Leverkusen negotiations between Bayer and Monsanto are by Reuters information currently at an impasse. The US seed giant had not yet opened about two weeks after the rejection of the 62 billion dollar Bayer offer his books for Leverkusen, said people familiar with the matter on Friday. Monsanto had declared on May 24, the current Bayer offer is financially inadequate and review Monsanto clearly too low. In addition, it does not sufficiently cover the financial and regulatory risks. Monsanto was but ready for talks on ways to provide an appropriate value for shareholders.
Bayer but have no plans for a higher offer if the company get more confidential information of Monsanto not in return, it said continue. The Leverkusen-based company need insight into the books before he could decide on raising the bid. Bayer currently do not intend to give a hostile bid for Monsanto. Monsanto’s lack of commitment show not only that the American seed giant Bayers offer too low consider, but also that he did not even look at it as a basis for discussions. Bayer did not want to comment on that. When Monsanto first opinion was to obtain. The “Wall Street Journal” had previously reported that Bayer had submitted a new offer for the same price. Monsanto got flagged
Monsanto takeover by Bayer . masterstroke or megalomania?
had the new Bayer CEO Werner Baumann, the equivalent of approximately 55 billion-euro takeover offer announced just weeks after taking office. Dekkers was cited as a reason for his retirement at Bayer personal reasons: he wanted to spend more time with his family in the US
The Leverkusen-based company had less than three weeks before surprising the acquisition of seeds and crop protection specialists from the. USA announced. Major projects such as Monsanto takeover usually have but a month-long lead. After the Monsanto management had rejected the offer as too low, is now speculated about a possible price premium.
Monsanto takeover which banks Bayer risky billion Deal finance
The acquisition of the company is not only valid for financial reasons as a risk. Also because of the bad reputation of Monsanto are the takeover plans by Bayer in the criticism. The US company relies on GM seeds. He is accused also ruppiges behavior in dealing with customers. In addition, Monsanto sells the weedkiller glyphosate, which is suspected to be carcinogenic. Monsanto marketed glyphosate under the name “Roundup”.
No comments:
Post a Comment